Enamine | Latest News & Updates - Dec 20, 2024 Release
Enamine has made bicyclo[2.1.0]pentane, a previously rare scaffold, accessible for research...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following π‘
Enamine
π enamine.netEnamine is a privately owned chemical company established in 1991, specializing in the synthesis of building blocks and small molecular weight compound libraries. The company supports pharmaceutical, biotech, and academic institutions with innovative chemistry solutions, offering services such as custom synthesis, compound library design, and lead optimization support. Enamine is recognized for having the world's largest reputable collection of chemical compounds tailored for the life sciences industry.
Enamine - Latest News and Updates
- Enamine has made bicyclo[2.1.0]pentane, a previously rare scaffold, accessible for research.
- Enamine has introduced a curated set of over 100 nuisance compounds for bioassay integrity, available in an assay-ready screening plate.
- Enamine published a new paper on gem-difluorinated saturated oxygen heterocycles for drug discovery co-authored by Kostiantyn Melnykov, Oleksandr Liashuk, Serhii Holovach, Valeriia Shatnia, and Artur Horbenko.
- Enamine published new research on scalable methods for synthesizing spirocyclic proline building blocks valuable for drug discovery.
- Enamine Ltd. in Kyiv, Ukraine, contributed to a study on the effects of fluorination patterns on the physicochemical properties of gem-fluorinated O-heterocyclic substituents.
- Enamine researchers, including Pavel K. Mykhailiuk, have published a study on the synthesis and evaluation of 'angular' spirocyclic azetidines in drug discovery.
- Enamine is currently hiring an Associate Project Manager - Global Clinical Supplies in Latvia.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.